Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 24,750
+100 (0.41%)
Aug 14, 2025, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 272.72 billion as of August 14, 2025.
Market Cap
272.72B
Enterprise Value
227.75B
Revenue
29.43B
Ranking
n/a
PE Ratio
59.66
Stock Price
24,750.00
Market Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 272.72B, an increase of 45.91%. That is a compound annual growth rate of 78.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 272.72B | 54.49% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.52T |
| Celltrion | 38.80T |
| ALTEOGEN | 23.35T |
| Yuhan | 8,487.38B |
| Peptron | 8,130.78B |
| SK Biopharmaceuticals | 7,878.31B |
| PharmaResearch | 6,909.12B |
| LigaChem Biosciences | 5,666.20B |